Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Multiple antigen peptide vaccines against Plasmodium falciparum malaria.

Mahajan B, Berzofsky JA, Boykins RA, Majam V, Zheng H, Chattopadhyay R, de la Vega P, Moch JK, Haynes JD, Belyakov IM, Nakhasi HL, Kumar S.

Infect Immun. 2010 Nov;78(11):4613-24. doi: 10.1128/IAI.00533-10. Epub 2010 Sep 7.

2.

Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines.

Patarroyo ME, Patarroyo MA.

Acc Chem Res. 2008 Mar;41(3):377-86. doi: 10.1021/ar700120t. Epub 2008 Feb 12. Review.

PMID:
18266328
3.

Prime-boost vectored malaria vaccines: progress and prospects.

Hill AV, Reyes-Sandoval A, O'Hara G, Ewer K, Lawrie A, Goodman A, Nicosia A, Folgori A, Colloca S, Cortese R, Gilbert SC, Draper SJ.

Hum Vaccin. 2010 Jan;6(1):78-83. Epub 2010 Jan 18. Review.

PMID:
20061802
4.

T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites.

Nardin E, Munesinghe YD, Moreno A, Clavijo P, Calle MC, Edelman R, Davis J, Herrington D, Nussenzweig RS.

Mem Inst Oswaldo Cruz. 1992;87 Suppl 3:223-7. Review.

5.

Vaccines against malaria.

Hill AV.

Philos Trans R Soc Lond B Biol Sci. 2011 Oct 12;366(1579):2806-14. doi: 10.1098/rstb.2011.0091. Review.

6.

Strategies for developing multi-epitope, subunit-based, chemically synthesized anti-malarial vaccines.

Patarroyo ME, Cifuentes G, Bermúdez A, Patarroyo MA.

J Cell Mol Med. 2008 Oct;12(5B):1915-35. doi: 10.1111/j.1582-4934.2008.00174.x. Review.

7.

An HLA-based approach to the design of a CTL-inducing vaccine against Plasmodium falciparum.

Lalvani A, Aidoo M, Allsopp CE, Plebanski M, Whittle HC, Hill AV.

Res Immunol. 1994 Jul-Aug;145(6):461-8. Review. No abstract available.

PMID:
7534937
8.

Malaria-specific memory T cells: putative roles of different types of memory responses in immunity and disease.

Good MF, Zevering Y.

Res Immunol. 1994 Jul-Aug;145(6):455-60. Review. No abstract available.

PMID:
7534936
9.

Recent advances in recombinant protein-based malaria vaccines.

Draper SJ, Angov E, Horii T, Miller LH, Srinivasan P, Theisen M, Biswas S.

Vaccine. 2015 Dec 22;33(52):7433-43. doi: 10.1016/j.vaccine.2015.09.093. Epub 2015 Oct 11. Review.

10.

Prospects and strategies for development of DNA vaccines against malaria.

Hedstrom RC, Sedegah M, Hoffman SL.

Res Immunol. 1994 Jul-Aug;145(6):476-83. Review. No abstract available.

PMID:
7899711
11.

Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design.

Garcia JE, Puentes A, Patarroyo ME.

Clin Microbiol Rev. 2006 Oct;19(4):686-707. Review.

12.

Plasmodium immunomics.

Doolan DL.

Int J Parasitol. 2011 Jan;41(1):3-20. doi: 10.1016/j.ijpara.2010.08.002. Epub 2010 Sep 16. Review.

13.

Invasion of red blood cells by malaria parasites--what are the components that determine specificity?

van Schravendijk MR, Wilson RJ, Pasvol G.

Ann Inst Pasteur Microbiol (1985). 1986 May-Jun;137A(3):342-7. Review. No abstract available.

PMID:
2447821
14.

Benchmarking B-cell epitope prediction for the design of peptide-based vaccines: problems and prospects.

Caoili SE.

J Biomed Biotechnol. 2010;2010:910524. doi: 10.1155/2010/910524. Epub 2010 Mar 30. Review.

15.

Clustered carbohydrates in synthetic vaccines.

Peri F.

Chem Soc Rev. 2013 Jun 7;42(11):4543-56. doi: 10.1039/c2cs35422e. Epub 2012 Dec 18. Review.

Supplemental Content

Support Center